Taylor Wessing advises Apax Partners and Merlin Biosciences on a $35 million private equity deal
17-Nov-2006 | Corporate, Life Sciences & Healthcare
CLIENT
Apax Partners and Merlin Biosciences
VALUE
$35 million
TRANSACTION
Private equity financing
DESCRIPTION
Advised Apax Partners France and Merlin Biosciences in a £35 million private equity financing led by Burrill and Company in a US biotech company specialising in the development of innovative sight-saving therapeutics for chronic retinal diseases
